PROT# CFTY720D2306: A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 1.25mg FTY720 Administered Orally Once Daily Versus Placebo in Patients with Primary Progressive Multiple Sclerosis
- Sufit, Robert L (Co-Investigator)
- Cohen, Bruce Arnold (PD/PI)
Project: Research project